This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Fidia Farmaceutici S.p.a.. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2025
Title: Riccardo Beninatto: Innovator in 3D Printing Technologies
Introduction
Riccardo Beninatto is a notable inventor based in Abano Terme, Italy. He has made significant contributions to the field of 3D printing, particularly in the development of bio-inks. With a total of 2 patents to his name, Beninatto is recognized for his innovative approaches to creating materials that can be used in medical applications.
Latest Patents
Beninatto's latest patents include a method for 3D printing with a bio-ink. This bio-ink is designed for use in 3D printing and involves a conjugate and a preparation process of an intermediate consisting of a bifunctional photoreactive linker. The bio-inks developed by Beninatto are utilized for manufacturing constructs through 3D printing. Another significant patent involves photocrosslinked hyaluronic acid derivatives. These derivatives consist of hyaluronic acid, a bifunctional polyethylene glycol spacer, and a photoreactive compound selected from a coumarin derivative and propiophenone.
Career Highlights
Riccardo Beninatto works at Fidia Farmaceutici S.p.a., where he continues to push the boundaries of innovation in the pharmaceutical and biomedical fields. His work focuses on enhancing the capabilities of 3D printing technologies to create more effective medical solutions.
Collaborations
Beninatto collaborates with talented individuals such as Monica Campisi and Ottorino De Lucchi. Their combined expertise contributes to the advancement of their projects and the successful development of new technologies.
Conclusion
Riccardo Beninatto is a pioneering inventor whose work in 3D printing and bio-inks is shaping the future of medical technology. His patents reflect a commitment to innovation and the potential for significant advancements in healthcare applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
